title: Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
abstract: Interleukin-7 (IL-7) is a crucial cytokine involved in T-cell survival and development but its signalling in human T cells, particularly in effector/memory T cells, is poorly documented. In this study, we found that IL-7 protects human CD4(+) effector/memory T cells from apoptosis induced upon the absence of stimulation and cytokines. We show that IL-7 up-regulates not only Bcl-2 but also Bcl-xL and Mcl-1 as well. Interleukin-7-induced activation of the janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway is sufficient for cell survival and up-regulation of Bcl-2 proteins. In contrast to previous studies with naive T cells, we found that IL-7 is a weak activator of the phosphatidylinositol 3 kinase (PI3K)/AKT (also referred as protein kinase B) pathway and IL-7-mediated cell survival occurs independently from the PI3K/AKT pathway as well as from activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Considering the contribution of both IL-7 and CD4(+) effector/memory T cells to the pathogenesis of autoimmune diseases such as rheumatoid arthritis and colitis, our study suggests that IL-7 can contribute to these diseases by promoting cell survival. A further understanding of the mechanisms of IL-7 signalling in effector/memory T cells associated with autoimmune inflammatory diseases may lead to potential new therapeutic avenues.
authors.affiliation: Centre de Recherche en Rhumatologie/Immunologie, Centre Hospitalier Universitaire de Québec, Pavillon CHUL, and Faculté de Médecine, Université Laval, Québec, PQ, Canada.
authors.forename: Nizar
authors.initials: N
authors.lastname: Chetoui
authors.forename: Marc
authors.initials: M
authors.lastname: Boisvert
authors.forename: Steve
authors.initials: S
authors.lastname: Gendron
authors.forename: Fawzi
authors.initials: F
authors.lastname: Aoudjit
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000276:immunology; D002070:Butadienes / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D053148:Caspase 3 / Q000378:metabolism; D061945:Caspase Inhibitors; D002470:Cell Survival / Q000187:drug effects / Q000276:immunology; D002867:Chromones / Q000494:pharmacology; D016207:Cytokines / Q000172:deficiency; D004791:Enzyme Inhibitors / Q000494:pharmacology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007156:Immunologic Memory / Q000187:drug effects*; D007376:Interleukin-2 / Q000494:pharmacology; D015851:Interleukin-7 / Q000276:immunology / Q000494:pharmacology*; D053699:Interleukin-7 Receptor alpha Subunit / Q000378:metabolism; D053612:Janus Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017493:Leukocyte Common Antigens / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology; D009025:Morpholines / Q000494:pharmacology; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009570:Nitriles / Q000494:pharmacology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D050791:STAT Transcription Factors / Q000378:metabolism*; D050799:STAT5 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects* / Q000276:immunology; D015854:Up-Regulation / Q000187:drug effects; D051020:bcl-X Protein / Q000378:metabolism
chemical_list: C494811:BCL2L1 protein, human; D002070:Butadienes; D061945:Caspase Inhibitors; D002867:Chromones; D016207:Cytokines; D004791:Enzyme Inhibitors; D007376:Interleukin-2; D015851:Interleukin-7; D053699:Interleukin-7 Receptor alpha Subunit; D009025:Morpholines; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009570:Nitriles; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D019253:Proto-Oncogene Proteins c-bcl-2; D050791:STAT Transcription Factors; D050799:STAT5 Transcription Factor; C113580:U 0126; D051020:bcl-X Protein; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D053612:Janus Kinases; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases; D017493:Leukocyte Common Antigens; D053148:Caspase 3
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11730-5
references.pmid: 17609371
references.citation: Immunol Cell Biol. 2008 Jan;86(1):57-66
references.pmid: 18026176
references.citation: Mol Cell. 2008 May 23;30(4):415-25
references.pmid: 18498746
references.citation: J Biol Chem. 2004 Jul 9;279(28):29160-6
references.pmid: 15123689
references.citation: Trends Immunol. 2004 Nov;25(11):610-5
references.pmid: 15489190
references.citation: J Immunol. 2003 Aug 1;171(3):1172-82
references.pmid: 12874203
references.citation: J Leukoc Biol. 2009 Mar;85(3):526-38
references.pmid: 19095735
references.citation: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14476-81
references.pmid: 10588730
references.citation: J Exp Med. 2004 Nov 1;200(9):1189-95
references.pmid: 15504823
references.citation: Eur J Immunol. 2003 Apr;33(4):913-9
references.pmid: 12672057
references.citation: Immunobiology. 2007;212(8):629-36
references.pmid: 17869640
references.citation: Immunol Rev. 2003 Jun;193:48-57
references.pmid: 12752670
references.citation: J Exp Med. 2003 Dec 15;198(12):1797-806
references.pmid: 14662907
references.citation: Mol Cell Biol. 2004 Jul;24(14):6501-13
references.pmid: 15226449
references.citation: Blood. 2008 Feb 15;111(4):2101-11
references.pmid: 18042802
references.citation: Immunity. 1997 Jul;7(1):147-54
references.pmid: 9252127
references.citation: Immunity. 2008 Dec 19;29(6):848-62
references.pmid: 19100699
references.citation: J Immunol. 1999 Sep 15;163(6):3131-7
references.pmid: 10477579
references.citation: Eur J Immunol. 2006 Jul;36(7):1694-706
references.pmid: 16761315
references.citation: J Immunol. 2008 Jul 1;181(1):521-8
references.pmid: 18566418
references.citation: J Immunol. 2008 Jun 15;180(12):8109-17
references.pmid: 18523275
references.citation: Immunol Rev. 2003 Jun;193:70-81
references.pmid: 12752672
references.citation: J Exp Med. 2003 Dec 15;198(12):1807-15
references.pmid: 14676295
references.citation: Cytokine. 2007 Jul;39(1):75-83
references.pmid: 17768066
references.citation: Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):513-33
references.pmid: 15996891
references.citation: Eur J Immunol. 2007 Nov;37(11):3078-88
references.pmid: 17935075
references.citation: Immunol Invest. 2004 May;33(2):109-42
references.pmid: 15195693
references.citation: J Biol Chem. 2009 Oct 9;284(41):28004-28020
references.pmid: 19667065
references.citation: Biotechniques. 2002 Oct;Suppl:40-5
references.pmid: 12395926
references.citation: J Immunol. 2005 Oct 1;175(7):4400-7
references.pmid: 16177081
references.citation: J Leukoc Biol. 2007 Sep;82(3):645-56
references.pmid: 17554014
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13759-64
references.pmid: 12354940
references.citation: Mol Immunol. 2003 Jun;39(16):983-93
references.pmid: 12749905
references.citation: Curr Opin Gastroenterol. 2009 Jul;25(4):306-13
references.pmid: 19448533
references.citation: Eur J Immunol. 1995 Nov;25(11):3041-6
references.pmid: 7489741
references.citation: J Immunol. 2006 Jun 1;176(11):6702-8
references.pmid: 16709829
references.citation: Nat Immunol. 2000 Nov;1(5):426-32
references.pmid: 11062503
references.citation: Annu Rev Immunol. 2004;22:765-87
references.pmid: 15032596
references.citation: Ann Rheum Dis. 2006 Nov;65 Suppl 3:iii69-74
references.pmid: 17038478
references.citation: Immunology. 2008 Nov;125(3):359-69
references.pmid: 18479350
references.citation: Curr Opin Immunol. 2007 Oct;19(5):516-21
references.pmid: 17644328
references.citation: Nat Rev Immunol. 2007 Jul;7(7):532-42
references.pmid: 17589543
references.citation: J Immunol. 2008 Feb 1;180(3):1490-8
references.pmid: 18209044
references.citation: Nature. 2003 Dec 11;426(6967):671-6
references.pmid: 14668867
references.citation: Oncogene. 2008 Dec;27 Suppl 1:S53-70
references.pmid: 19641507
references.citation: J Immunol. 2005 Jun 1;174(11):6571-6
references.pmid: 15905493
references.citation: J Immunol. 2007 Apr 15;178(8):4737-48
references.pmid: 17404253
references.citation: J Biol Chem. 2003 Dec 5;278(49):48633-43
references.pmid: 13679375
references.citation: J Exp Med. 2004 Sep 6;200(5):659-69
references.pmid: 15353558
references.citation: Genes Dev. 2003 Aug 1;17(15):1841-54
references.pmid: 12869584
references.citation: J Immunol. 2009 Jul 1;183(1):261-9
references.pmid: 19542438
references.citation: J Biol Chem. 1995 Jun 16;270(24):14517-22
references.pmid: 7782314
references.citation: Immunity. 2004 Aug;21(2):289-302
references.pmid: 15308108